Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies
Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114239-114239
Open Access | Times Cited: 19

Showing 19 citing articles:

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 43
Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation
Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10304-10321
Open Access | Times Cited: 11
Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer’s disease: Design, synthesis, in-vitro, in-vivo and in-silico studies
Fahad Hussain, Ayesha Tahir, Hafiz Muzzammel Rehman, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117327-117327
Closed Access | Times Cited: 1
New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies
Mohammed Ayed Huneif, Mater H. Mahnashi, Muhammad Saeed Jan, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1207-1207
Open Access | Times Cited: 21
Isolation, invitro, invivo anti-inflammatory, analgesic and antioxidant potential of Habenaria plantegania Lindl
Osama M. Alshehri, Madeeha Shabnam, Saeed Ahmed Asiri, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1353-1369
Closed Access | Times Cited: 4
Progress in the study of anti-Alzheimer's disease activity of pyrimidine-containing bioactive molecules
Yulin Liu, Qian Zhang, Bingqian Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117199-117199
Closed Access
Synthesis, Pharmacological Evaluation, and Molecular Modeling of Phthalimide Derivatives as Monoamine Oxidase and Cholinesterase Dual Inhibitors
Nabiha Abdullah, Fahad Hussain, Naseem Ullah, et al.
ACS Omega (2025) Vol. 10, Iss. 10, pp. 10385-10400
Open Access
Evaluation of the Memory Enhancement Effects of Aminopyrimidine Derivatives Using the Scopolamine Model of Dementia in Mice
Behnaz Landi, Mona Khoramjouy, Alireza Ghavami Lahij, et al.
Neurotoxicity Research (2025) Vol. 43, Iss. 2
Closed Access
In vitro and in silico antiproliferative potential of isolated flavonoids constitutes from Pistacia integerrima
Abdur Rauf, Umer Rashid, Zuneera Akram, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 7-8, pp. 187-193
Open Access | Times Cited: 3
System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson’s disease: a network pharmacology and in-silico evaluation
Gomathy Subramanian, Hannah Lalengzuali Fanai, Jagdish Chand, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches
Mater H. Mahnashi, Waqas Alam, Mohammed Ayed Huneif, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1589-1589
Open Access | Times Cited: 5
Ferulago Angulata methanolic extract ameliorates scopolamine-induced memory impairment through the inhibition of hippocampal monoamine oxidase activity
Samaneh hajimohammadi, Maliheh Soodi, Homa Hajimehdipoor, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 691-703
Closed Access | Times Cited: 1
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Ameliorative role of diets fortified with Artocarpus altilis in a Drosophila melanogaster model of aluminum chloride-induced neurotoxicity
Jamiyu A. Saliu, Ayobami Matthew Olajuyin, Samuel Faith Olowolayemo
Clinical Phytoscience (2024) Vol. 10, Iss. 1
Open Access
Design, Synthesis and Evaluation of 8‐(Piperazin‐1‐yl) Imidazo[1,2‐a]Pyrazine Derivatives as Acetylcholinesterase Inhibitors and Antioxidants
Ben-Ben Wei, Wen-Rong Du, Xin-Yuan Guo, et al.
ChemistrySelect (2024) Vol. 9, Iss. 14
Open Access
Antileishmanial potential of thiourea-based derivatives: design, synthesis and biological activity
Abdul Hadi Abd Rahman, Muhammad Yaqoob, Fahad Hussain, et al.
RSC Advances (2024) Vol. 14, Iss. 50, pp. 37131-37141
Open Access
Design, Synthesis and Evaluation of 8-(Piperazin-1-Yl)Imidazo[1,2-A]Pyrazine Derivatives as Acetylcholinesterase Inhibitors and Antioxidants
Ben-Ben Wei, Xin-Yuan Guo, Wen-Rong Du, et al.
(2023)
Open Access
Pharmacological Evaluation and Molecular Docking of Novel Synthesized Pyrazolopyrimidine Derivatives
Rawan Bafail, Waad A. Samman, Marwa Alsulaimany, et al.
(2023)
Open Access
Design, Synthesis and Evaluation of 8-(piperazin-1-yl)imidazo[1,2-a]pyrazine Derivatives as Acetylcholinesterase Inhibitors and Antioxidants
Ben-Ben Wei, Wen-Rong Du, Xin-Yuan Guo, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top